DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹7,734 Cr | ₹4,677 Cr | ₹2,002 Cr | ₹1,347 Cr | ₹3,385 Cr |
What is the latest Total Debt ratio of DR REDDYS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹7,734 Cr |
| Mar2025 | ₹4,677 Cr |
| Mar2024 | ₹2,002 Cr |
| Mar2023 | ₹1,347 Cr |
| Mar2022 | ₹3,385 Cr |
How is Total Debt of DR REDDYS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,734 Cr | 65.38 | |
| Mar2025 | ₹4,677 Cr | 133.60 | |
| Mar2024 | ₹2,002 Cr | 48.60 | |
| Mar2023 | ₹1,347 Cr | -60.20 | |
| Mar2022 | ₹3,385 Cr | - | |
Compare Total Debt of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹100,197.4 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| MANKIND PHARMA | ₹102,229.0 Cr | 6.8% | 4.6% | -6.7% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 2.5% |
0.8% |
-8.5% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses